| __timestamp | Dynavax Technologies Corporation | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84580000 | 31354781 |
| Thursday, January 1, 2015 | 86943000 | 43445817 |
| Friday, January 1, 2016 | 84493000 | 66489820 |
| Sunday, January 1, 2017 | 64988000 | 96886134 |
| Monday, January 1, 2018 | 74951000 | 153793000 |
| Tuesday, January 1, 2019 | 62331000 | 148369000 |
| Wednesday, January 1, 2020 | 28607000 | 151934000 |
| Friday, January 1, 2021 | 32228000 | 198532000 |
| Saturday, January 1, 2022 | 46600000 | 112128000 |
| Sunday, January 1, 2023 | 54886000 | 76192000 |
Unleashing insights
In the ever-evolving world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, TG Therapeutics, Inc. and Dynavax Technologies Corporation have demonstrated contrasting trajectories in their R&D investments. From 2014 to 2023, TG Therapeutics increased its R&D expenses by approximately 143%, peaking in 2021. This surge underscores their aggressive pursuit of new therapies. In contrast, Dynavax's R&D spending saw a decline of about 35% from its 2015 peak, reflecting a strategic shift or potential resource reallocation. By 2023, TG Therapeutics' R&D expenses were nearly 39% higher than Dynavax's, highlighting their divergent paths. This comparison not only sheds light on each company's strategic priorities but also offers insights into the broader trends shaping the biotech industry.
Comparing Innovation Spending: Novo Nordisk A/S and Dynavax Technologies Corporation
Analyzing R&D Budgets: Novartis AG vs Dynavax Technologies Corporation
R&D Insights: How Pfizer Inc. and TG Therapeutics, Inc. Allocate Funds
R&D Insights: How Bristol-Myers Squibb Company and TG Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Gilead Sciences, Inc. vs TG Therapeutics, Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Dynavax Technologies Corporation
Neurocrine Biosciences, Inc. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Dynavax Technologies Corporation
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.
TG Therapeutics, Inc. or Galapagos NV: Who Invests More in Innovation?
Comparing Innovation Spending: Vericel Corporation and Dynavax Technologies Corporation
Catalyst Pharmaceuticals, Inc. or Dynavax Technologies Corporation: Who Invests More in Innovation?